We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 447.50 | 440.00 | 455.00 | 447.50 | 447.50 | 447.50 | 9,059 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 47.56 | 212.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/4/2021 23:16 | Parker Laboratory sounds promising. Spiderman, Spiderman. Does everything a spider can. | mach100 | |
08/4/2021 22:52 | Tristel Global@TristelGlobal @STSFTrust recently installed two Tristel RA systems within their temporary endoscopy unit. Great to see Tristel RA in action! Tristel RA combines Reverse Osmosis, filtration and low doses of chlorine dioxide for bacteria-free rinse water every time: | piedro | |
02/4/2021 12:16 | TRISTEL: P/E Reaches Stratospheric 48x As H1 Figures Reveal Profit Improving Up To 31% And Headcount Increasing 19% To Prepare For Future Growth 09 March 2021 By Maynard Paton | piedro | |
31/3/2021 16:36 | 2 Parker Laboratory products: PROTEX® DISINFECTANT SPRAY AQUASONIC® 100 ULTRASOUND TRANSMISSION GEL | piedro | |
31/3/2021 16:31 | edwardt, The US decision will come when it comes... You ought be content with ... "this year, next year, sometime, never ..." ... beceause when it comes sales will depend on Parker Laboratories. {I shall be with fingers crossed that they do not just sit on the product as seems to have happened with the Clorox deal}. This is all we know of the contract ... "Parker will manufacture Tristel's Duo chlorine dioxide foam disinfectant for the North, Central and South American market and will market the product in the ultrasound marketplace throughout the region." | piedro | |
30/3/2021 22:23 | Tristel Global@TristelGlobal Designed for rapid sporicidal surface disinfection in contamination control environments, TITANIUM kills microorganisms of concern in 60 seconds. Find out more about TITANIUM here: | piedro | |
23/3/2021 12:08 | how long does the US decision take? anyone know likely timeframe.... | edwardt | |
22/3/2021 12:23 | yep but the vaccine effect should change the picture in Europe too in the coming weeks - otherwise as the guy from dad's army used to say - "we're all doomed" !!. its the old and vulnerable that take up most hospital time and they will be the people getting vaccinated in Europe and ROW right now I guess ..... as long as there are no more pauses re blood clots.. | melody9999 | |
22/3/2021 11:33 | Except, whilst the UK improves, Tristel's other big market of central Europe is going back into lockdown.So no net gain yet. | paulisi | |
22/3/2021 08:37 | added late last week. Should be good times for TSTL now as hospital operations get into full flow - at least in the uk with other countries following - meanwhile surface disinfections continue apace. | melody9999 | |
02/3/2021 08:47 | More shares printed yesterday at no one is watching time. 46,998,443 apad | apad | |
25/2/2021 13:33 | Look at todays headlines from Reckitt & Benckiser - Keep everything clean is the punch line and it struck me that if RB wanted £270m TSTL then at a big premium on todays price that would hardly move the richter scale as far as cash flow is concerned. In todays world and cheap money TSTL does not move fast enough.......... | anley | |
24/2/2021 11:39 | May the trend be your friend ... | piedro | |
23/2/2021 17:25 | There are many possible reasons for the recent TSTL share price activity (including IG recently deciding to withdraw from small cap stocks), but it does not matter much to medium and long term holders. Over time in recent years, the share price trajectory has been excellent and there is an obvious roll out strategy which is by no means solely reliant on North America. The company has barely got started in South-East Asia, has no presence in South America and is now projecting initial sales in India next month. The fact that the company remains debt free and relatively conservative are significant plusses for me. The end game may well be TSTL being acquired by a much larger fish, but why not enjoy the ride? | james188 | |
23/2/2021 16:46 | You stick with the PE and I will keep to how I see things. If this company had a quote on say NASDAQ then the PE would be double but the board will carry on their progress without debt and basically ignoring everyone else..... | anley | |
23/2/2021 12:20 | Anley I said I think it is getting punished for its high P/E and not just the MM's that are taking it down. In facr it sank in the run up to results if you remember being near 700p and and 610p pre results. Added more myself last week at 635p and I too have faith in the company longer term I hope though that the fall stabilises around this price. | mach100 | |
23/2/2021 11:25 | MACH100........not sure what you are trying to say but for me there is a question of the share moving too fast and when you get a market wabble the first people to are the MM who adjust their books..............I think this is what has happened here. The hygene story has not changed for me and in fact it looks as if we shall all be wearing marsks in certain circumstances for ever.......so its a steady growth story and as someone mentioned it could even be a T/O story as and when some of the board get boared. | anley | |
23/2/2021 10:29 | Getting punished on the P/E today I think. Anyone else's PF going down substantially in the last two weeks? After a really good run it seems everyday is a down day.doesn;t help that my PF is Tristel and ITM centric. However the yield is driven up here as it sinks and worth looking for a bottom. I think the market in general was overheated so a little froth being blown away is good. I hope none of the Board has sold since the results as it will further dent confidence. | mach100 | |
22/2/2021 22:35 | Hi all, new article on Tristel - a review of interims and investment case, available here: hxxps://www.thetwent | thetwentiestrader | |
22/2/2021 17:47 | Personally I never set targets - I'll let it trend as far as it wants to go | davr0s | |
22/2/2021 13:03 | I’m looking £10 price target in the next12 months and that may me slightly conservative | best1467 | |
22/2/2021 12:05 | Lot of negativity here today. I hold, am not bored of it. Up on a risk off day | davr0s | |
22/2/2021 11:05 | Results Presentation now on website - yawn!! - how tired they sound | piedro | |
22/2/2021 09:25 | At best I see this long term as a hundred million turnover once their new markets mature and I would expect, some of the big players to be interested and a buyout maybe the best option for the company. | paulisi | |
22/2/2021 09:02 | TSTL as expected. Of note: Net cash up. Increased divi. 31 more staff in the 6 months to December. They say there is no new competition, but there is a Danish company with disposable endoscopes. i expect some PI boredom to set in. apad | apad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions